MicroRNAs: A complex regulatory network drives the acquisition of malignant cell phenotype

Endocrine-Related Cancer

Volumn 17, Issue 1, 2010, Pages

  Santarpia, Libero ^a,b   Nicoloso, Milena ^b   Calin, George A ^b  

^a Translational Research Unit   (Italy)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

ADRENAL TUMOR; ANGIOGENESIS; APOPTOSIS; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; ENDOCRINE GLAND; ENDOCRINE TUMOR; GENE CONTROL; GENE EXPRESSION; GENE TARGETING; HUMAN; HYPOPHYSIS TUMOR; LIVER CANCER; METASTASIS; MOLECULAR MECHANICS; NONHUMAN; OVARY CANCER; PANCREAS CANCER; PHENOTYPE; PROSTATE CANCER; PROTEIN FUNCTION; REVIEW; STOMACH CANCER; THYROID TUMOR;

ANIMALS; APOPTOSIS; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; COCARCINOGENESIS; DISEASE PROGRESSION; ENDOCRINE GLAND NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MODELS, BIOLOGICAL; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASMS, HORMONE-DEPENDENT; NEOVASCULARIZATION, PATHOLOGIC; RNA, NEOPLASM;

EID: 77449152336     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-09-0222     Document Type: Review

References (218)

1. Akao Y, Nakagawa Y & Naoe T 2006 MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers. Oncology Reports 16 845-850.
2. Akao Y, Nakagawa Y & Naoe T 2007 MicroRNA-143 and-145 in colon cancer. DNA and Cell Biology 26 311-320.
3. Amaral FC, Torres N, Saggioro F, Neder L, Machado HR, Silva WA Jr, Moreira AC & Castro M 2009 MicroRNAs differentially expressed in ACTH-secreting pituitary tumors. Journal of Clinical Endocrinology and Metabolism 94 320-323.
4. Ambros V 2008 The evolution of our thinking about microRNAs. Nature Medicine 14 1036-1040.
5. Ambs S, Prueitt RL, Yi M, Hudson RS, Howe TM, Petrocca F, Wallace TA, Liu CG, Volinia S, Calin GA et al. 2008 Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Research 68 6162-6170.
6. Apte SM, Bucana CD, Killion JJ, Gershenson DM & Fidler IJ 2004 Expression of platelet-derived growth factor and activated receptor in clinical specimens of epithelial ovarian cancer and ovarian carcinoma cell lines. Gynecologic Oncology 93 78-86.
7. Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, Post S & Allgayer H 2008 MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27 2128-2136.
8. Bailey SM, Brenneman MA & Goodwin EH 2004 Frequent recombination in telomeric DNA may extend the proliferative life of telomerase-negative cells. Nucleic Acids Research 32 3743-3751.
9. Baldassarre G, Belletti B, Nicoloso MS, Schiappacassi M, Vecchione A, Spessotto P, Morrione A, Canzonieri V & Colombatti A 2005 p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion. Cancer Cell 7 51-63.
10. Bandi N, Zbinden S, Gugger M, Arnold M, Kocher V, Hasan L, Kappeler A, Brunner T & Vassella E 2009 miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer. Cancer Research 69 5553-5559.
11. Bandres E, Bitarte N, Arias F, Agorreta J, Fortes P, Agirre X, Zarate R, Diaz-Gonzalez JA, Ramirez N, Sola JJ et al. 2009 microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells. Clinical Cancer Research 15 2281-2290.
12. Bartek J & Lukas J 2006 Cell biology. Balancing life-or-death decisions. Science 314 261-262.
13. Bartek J, Bartkova J & Lukas J 2007 DNA damage signalling guards against activated oncogenes and tumour progression. Oncogene 26 7773-7779.
14. Benetti R, Gonzalo S, Jaco I, Muñoz P, Gonzalez S, Schoeftner S, Murchison E, Andl T, Chen T, Klatt P et al. 2008 A mammalian microRNA cluster controls DNA methylation and telomere recombination via Rbl2-dependent regulation of DNA methyltransferases. Nature Structural and Molecular Biology 15 268-279.
15. Bhaumik D, Scott GK, Schokrpur S, Patil CK, Campisi J & Benz CC 2008 Expression of microRNA-146 suppresses NF-kB activity with reduction of metastatic potential in breast cancer cells. Oncogene 27 5643-5647.
16. Bjerkvig R, Tysnes BB, Aboody KS, Najbauer J & Terzis AJ 2005 Opinion: the origin of the cancer stem cell: current controversies and new insights. Nature Reviews. Cancer 5 899-904.
17. Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, Hagan JP, Liu CG, Bhatt D, Taccioli C & Croce CM 2007 MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. Journal of the American Medical Association 297 1901-1908.
18. Bommer GT, Gerin I, Feng Y, Kaczorowski AJ, Kuick R, Love RE, Zhai Y, Giordano TJ, Qin ZS, Moore BB et al. 2007 p53-Mediated activation of miRNA34 candidate tumor-suppressor genes. Current Biology 17 1298-1307.
19. Bonci D, Coppola V, Musumeci M, Addario A, Giuffrida R, Memeo L, D'Urso L, Pagliuca A, Biffoni M, Labbaye C et al. 2008 The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nature Medicine 14 1271-1277.
20. Bottoni A, Piccin D, Tagliati F, Luchin A, Zatelli MC & degli Uberti EC 2005 miR-15a and miR-16-1 down-regulation in pituitary adenomas. Journal of Cellular Physiology 204 280-285.
21. Braun CJ, Zhang X, Savelyeva I, Wolff S, Moll UM, Schepeler T, Ørntoft TF, Andersen CL & Dobbelstein M 2008 p53-Responsive microRNAs 192 and 215 are capable of inducing cell cycle arrest. Cancer Research 68 10094-10104.
22. Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Spaderna S & Brabletz T 2008 A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Reports 9 582-589.
23. Calin GA & Croce CM 2006 MicroRNA signatures in human cancers. Nature Reviews. Cancer 6 857-866.
24. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M et al. 2004 Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. PNAS 101 2999-3004.
25. Calin GA, Cimmino A, Fabbri M, Ferracin M, Wojcik SE, Shimizu M, Taccioli C, Zanesi N, Garzon R, Aqeilan RI et al. 2008 MiR-15a and miR-16-1 cluster functions in human leukemia. PNAS 105 5166-5171.
26. Campisi J 2005 Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120 513-522.
27. Cao X, Pfaff SL & Gage FH 2007 A functional study of miR-124 in the developing neural tube. Genes and Development 21 531-536.
28. Chambers AF, Groom AC & MacDonald IC 2002 Dissemination and growth of cancer cells in metastatic sites. Nature Reviews. Cancer 2 563-572.
29. Chan JA, Krichevsky AM & Kosik KS 2005 MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Research 65 6029-6033.
30. Chang J, Nicolas E, Marks D, Sander C, Lerro A, Buendia MA, Xu C, Mason WS, Moloshok T, Bort R et al. 2004 miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biology 1 106-113.
31. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, Feldmann G, Yamakuchi M, Ferlito M, Lowenstein CJ et al. 2007 Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Molecular Cell 26 745-752.
32. Chayka O, Corvetta D, Dews M, Caccamo AE, Piotrowska I, Santilli G, Gibson S, Sebire NJ, Himoudi N, Hogarty MD et al. 2009 Clusterin, a haploinsufficient tumor suppressor gene in neuroblastomas. Journal of the National Cancer Institute 101 663-677.
33. Chen Y & Gorski DH 2008 Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5. Blood 111 1217-1226.
34. Chen RW, Bemis LT, Amato CM, Myint H, Tran H, Birks DK, Eckhardt SG & Robinson WA 2008 Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma. Blood 112 822-829.
35. Chen X, Guo X, Zhang H, Xiang Y, Chen J, Yin Y, Cai X, Wang K, Wang G, Ba Y et al. 2009 Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene 28 1385-1392.
36. Chu IM, Hengst L & Slingerland JM 2008 The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nature Reviews. Cancer 8 253-267.
37. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M et al. 2005 miR-15 and miR-16 induce apoptosis by targeting BCL2. PNAS 102 13944-13949.
38. Cole KA, Attiyeh EF, Mosse YP, Laquaglia MJ, Diskin SJ, Brodeur GM & Maris JM 2008 A functional screen identifies miR-34a as a candidate neuroblastoma tumour suppressor gene. Molecular Cancer Research 6 735-742.
39. Coller HA, Forman JJ & Legesse-Miller A 2007 "Myc'ed messages": myc induces transcription of E2F1 while inhibiting its translation via a microRNA polycistron. PLoS Genetics 3 e146.
40. Corsten MF, Miranda R, Kasmieh R, Krichevsky AM, Weissleder R & Shah K 2007 MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Research 67 8994-9000.
41. Coulouarn C, Factor VM, Andersen JB, Durkin ME & Thorgeirsson SS 2009 Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene 28 3526-3536.
42. Dahiya N, Sherman-Baust CA, Wang TL, Davidson B, Shih IeM, Zhang Y, Wood WIII, Becker KG & Morin PJ 2008 MicroRNA expression and identification of putative miRNA targets in ovarian cancer. PLoS One 3 e2436.
43. Dews M, Homayouni A, Yu D, Murphy D, Sevignani C, Wentzel E, Furth EE, Lee WM, Enders GH, Mendell JT et al. 2006 Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nature Genetics 38 1060-1065.
44. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O et al. 1995 A biomarker that identifies senescent human cells in culture and in aging skin in vivo. PNAS 92 9363-9367.
45. Du Y, Xu Y, Ding L, Yao H, Yu H, Zhou T & Si J 2009 Down-regulation of miR-141 in gastric cancer and its involvement in cell growth. Journal of Gastroenterology 44 556-561.
46. Dutta KK, Zhong Y, Liu YT, Yamada T, Akatsuka S, Hu Q, Yoshihara M, Ohara H, Takehashi M, Shinohara T et al. 2007 Association of microRNA-34a overexpression with proliferation is cell type-dependent. Cancer Science 98 1845-1852.
47. Eberhart JK, He X, Swartz ME, Yan YL, Song H, Boling TC, Kunerth AK, Walker MB, Kimmel CB & Postlethwait JH 2008 MicroRNA Mirn140 modulates Pdgf signaling during palatogenesis. Nature Genetics 40 290-298.
48. Epis MR, Giles KM, Barker A, Kendrick TS & Leedman PJ 2009 miR-331-3p regulates ERBB-2 expression and androgen receptor signaling in prostate cancer. Journal of Biological Chemistry 284 24696-24704.
49. Esquela-Kerscher A, Trang P, Wiggins JF, Patrawala L, Cheng A, Ford L, Weidhaas JB, Brown D, Bader AG & Slack FJ 2008 The let-7 microRNA reduces tumor growth in mouse models of lung cancer. Cell Cycle 7 759-764.
50. Fasanaro P, D'Alessandra Y, Di Stefano V, Melchionna R, Romani S, Pompilio G, Capogrossi MC & Martelli F 2008 MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine-kinase ligand Ephrin-A3. Journal of Biological Chemistry 283 15878-15883.
51. Fish JE, Santoro MM, Morton SU, Yu S, Yeh RF, Wythe JD, Ivey KN, Bruneau BG, Stainier DY & Srivastava D 2008 miR-126 regulates angiogenic signaling and vascular integrity. Developmental Cell 15 272-284.
52. Foekens JA, Sieuwerts AM, Smid M, Look MP, de Weerd V, Boersma AW, Klijn JG, Wiemer EA & Martens JW 2008 Four miRNAs associated with aggressiveness of lymphnode-negative, estrogen receptor-positive human breast cancer. PNAS 105 13021-13026.
53. Fontana L, Fiori ME, Albini S, Cifaldi L, Giovinazzi S, Forloni M, Boldrini R, Donfrancesco A, Federici V, Giacomini P et al. 2008 Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM. PLoS One 3 e2236.
54. Fornari F, Gramantieri L, Ferracin M, Veronese A, Sabbioni S, Calin GA, Grazi GL, Giovannini C, Croce CM, Bolondi L et al. 2008 MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Oncogene 27 5651-5661.
55. Fornari F, Gramantieri L, Giovannini C, Veronese A, Ferracin M, Sabbioni S, Calin GA, Grazi GL, Croce CM, Tavolari S et al. 2009 MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Research 69 5761-5767.
56. Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A & Lund AH 2008 Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. Journal of Biological Chemistry 283 1026-1033.
57. Friedl P 2004 Prespecification and plasticity: shifting mechanisms of cell migration. Current Opinion in Cell Biology 16 14-23.
58. Friedl P & Wolf K 2003 Tumour-cell invasion and migration: diversity and escape mechanisms. Nature Reviews. Cancer 3 362-374.
59. Galardi S, Mercatelli N, Giorda E, Massalini S, Frajese GV, Ciafrè SA & Farace MG 2007 miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. Journal of Biological Chemistry 282 23716-23724.
60. Gandellini P, Folini M, Longoni N, Pennati M, Binda M, Colecchia M, Salvioni R, Supino R, Moretti R, Limonta P et al. 2009 miR-205 exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon. Cancer Research 69 2287-2295.
61. Georges SA, Biery MC, Kim SY, Schelter JM, Guo J, Chang AN, Jackson AL, Carleton MO, Linsley PS, Cleary MA et al. 2008 Coordinated regulation of cell cycle transcripts by p53-inducible microRNAs, miR-192 and miR-215. Cancer Research 68 10105-10112.
62. Gironella M, Seux M, Xie MJ, Cano C, Tomasini R, Gommeaux J, Garcia S, Nowak J,Yeung ML, Jeang KT et al. 2007 Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. PNAS 104 16170-16175.
63. Gorski DH & Walsh K 2003 Control of vascular cell differentiation by homeobox transcription factors. Trends in Cardiovascular Medicine 13 213-220.
64. Gramantieri L, Ferracin M, Fornari F, Veronese A, Sabbioni S, Liu CG, Calin GA, Giovannini C, Ferrazzi E, Grazi GL et al. 2007 Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Research 67 6092-6099.
65. Gramantieri L, Fornari F, Callegari E, Sabbioni S, Lanza G, Croce CM, Bolondi L & Negrini M 2008 MicroRNA involvement in hepatocellular carcinoma. Journal of Cellular and Molecular Medicine 12 2189-2204.
66. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y & Goodall GJ 2008 The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nature Cell Biology 10 593-601.
67. Grinstein E & Wernet P 2007 Cellular signaling in normal and cancerous stem cells. Cell Signalling 19 2428-2433.
68. Guo W, Pylayeva Y, Pepe A, Yoshioka T, Muller WJ, Inghirami G & Giancotti FG 2006 Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis. Cell 126 489-502.
69. Guo C, Sah JF, Beard L, Willson JK, Markowitz SD & Guda K 2008a The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers. Genes, Chromosomes & Cancer 47 939-946.
70. Hanahan D & Weinberg RA 2000 The hallmarks of cancer. Cell 100 57-70.
71. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe SW, Hannon GJ et al. 2005a A microRNA polycistron as a potential human oncogene. Nature 435 828-833.
72. He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S, Calin GA, Liu CG, Franssila K, Suster S et al. 2005b The role of microRNA genes in papillary thyroid carcinoma. PNAS 102 19075-19080.
73. He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y, Xue W, Zender L, Magnus J, Ridzon D et al. 2007 A microRNA component of the p53 tumour suppressor network. Nature 447 1130-1134.
74. Heaney AP & Melmed S 2005 Oncogenes and Tumor Suppressor Genes in Tumorigenesis of the Endocrine System. In Endocrinology: Basic and Clinical Principles. Eds S Melmed & MP Conn, 2nd Edn, pp 301-309. Humana Press: Heidelberg, Germany.
75. Heldin CH, Landström M & Moustakas A 2009 Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition. Current Opinion in Cell Biology 21 166-176.
76. Hermeking H 2009 ThemiR-34 family in cancer and apoptosis. Cell Death and Differentiation (Epub ahead of print).
77. Hiyoshi Y, Kamohara H, Karashima R, Sato N, Imamura Y, Nagai Y, Yoshida N, Toyama E, Hayashi N, Watanabe M et al. 2009 MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma. Clinical Cancer Research 15 1915-1922.
78. Hornstein E & Shomron N 2006 Canalization of development by microRNAs. Nature Genetics 38 (Suppl) S20-S24.
79. Hua Z, Lv Q, Ye W, Wong CK, Cai G, Gu D, Ji Y, Zhao C, Wang J, Yang BB et al. 2006 MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS One 1 e116.
80. Huang Q, Gumireddy K, Schrier M, le Sage C, Nagel R, Nair S, Egan DA, Li A, Huang G, Klein-Szanto AJ et al. 2008 The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nature Cell Biology 10 202-210.
81. Huang TH,WuF, Loeb GB, Hsu R, Heidersbach A, Brincat A, Horiuchi D, Lebbink RJ, Mo YY, Goga A et al. 2009 Up-regulation of miR-21 by HER2/neu signaling promotes cell invasion. Journal of Biological Chemistry 284 18515-18524.
82. Hurteau GJ, Carlson JA, Spivack SD & Brock GJ 2007 Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. Cancer Research 67 7972-7976.
83. Iaquinta PJ & Lees JA 2007 Life and death decisions by the E2F transcription factors. Current Opinion in Cell Biology 19 649-657.
84. Iliopoulos D, Bimpaki EI, Nesterova M & Stratakis CA 2009 MicroRNA signature of primary pigmented nodular adrenocortical disease: clinical correlations and regulation of Wnt signaling. Cancer Research 69 3278-3282.
85. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M et al. 2005 MicroRNA gene expression deregulation in human breast cancer. Cancer Research 65 7065-7070.
86. Iorio MV, Visone R, Di Leva G, Donati V, Petrocca F, Casalini P, Taccioli C, Volinia S, Liu CG, Alder H et al. 2007 MicroRNA signatures in human ovarian cancer. Cancer Research 67 8699-8707.
87. Iorio MV, Casalini P, Tagliabue E, Ménard S & Croce CM 2008 MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancer. European Journal of Cancer 44 2753-2759.
88. Iorio MV, Casalini P, Piovan C, Di Leva G, Merlo A, Triulzi T, Ménard S, Croce CM & Tagliabue E 2009 microRNA-205 regulates HER3 in human breast cancer. Cancer Research 69 2195-2200.
89. Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR & de la Chapelle A 2008 Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. PNAS 105 7269-7274.
90. Jazdzewski K, Liyanarachchi S, Swierniak M, Pachucki J, Ringel MD, JarzabB&de la Chapelle A 2009 Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer. PNAS 106 1502-1505.
91. Jiang J, Lee EJ, Gusev Y & Schmittgen TD 2005 Real-time expression profiling of microRNA precursors in human cancer cell lines. Nucleic Acids Research 33 5394-5403.
92. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D & Slack FJ 2005 RAS is regulated by the let-7 microRNA family. Cell 120 635-647.
93. Jopling CL, Yi M, Lancaster AM, Lemon SM & Sarnow P 2005 Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science 309 1577-1581.
94. Kim VN 2005 MicroRNA biogenesis: coordinated cropping and dicing. Nature Reviews. Molecular Cell Biology 6 376-385.
95. Kim JW, Wong CW, Goldsmith JD, Song C, Fu W, Allion MB, Herlyn M, Al-Mehdi AB & Muschel RJ 2004 Rapid apoptosis in the pulmonary vasculature distinguishes nonmetastatic from metastatic melanoma cells. Cancer Letters 213 203-212.
96. Kim HH, Kuwano Y, Srikantan S, Lee EK, Martindale JL & Gorospe M 2009 HuR recruits let-7/RISC to repress c-Myc expression. Genes and Development 23 1743-1748.
97. Kong W, Yang H, He L, Zhao JJ, Coppola D, Dalton WS & Cheng JQ 2008 MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting Rho A. Molecular and Cellular Biology 28 6773-6784.
98. Kong D, Li Y, Wang Z, Banerjee S, Ahmad A, Kim HR & Sarkar FH 2009 miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells. Stem Cells 27 1712-1721.
99. Korpal M, Lee ES, Hu G & Kang Y 2008 The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. Journal of Biological Chemistry 283 14910-14914.
100. Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, Hwang HW, Chang TC, Vivekanandan P, Torbenson M, Clark KR et al. 2009 Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137 1005-1017.
101. Krützfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M & Stoffel M 2005 Silencing of microRNAs in vivo with 'antagomirs'. Nature 438 685-689.
102. Kuehbacher A, Urbich C, Zeiher AM & Dimmeler S 2007 Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circulation Research 101 59-68.
103. Kulshreshtha R, Ferracin M, Wojcik SE, Garzon R, Alder H, Agosto-Perez FJ, Davuluri R, Liu CG, Croce CM, Negrini M et al. 2007 A microRNA signature of hypoxia. Molecular and Cellular Biology 27 1859-1867.
104. Kumamoto K, Spillare EA, FujitaK,Horikawa I,Yamashita T, Appella E, Nagashima M, Takenoshita S, Yokota J & Harris CC 2008 Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regulate mir-34a, mir-34b, and mir-34c expression, and induce senescence. Cancer Research 68 3193-3203.
105. Kumar MS, Erkeland SJ, Pester RE, Chen CY, Ebert MS, Sharp PA & Jacks T 2008 Suppression of non-small cell lung tumor development by the let-7 microRNA family. PNAS 105 3903-3908.
106. Laneve P, Di Marcotullio L, Gioia U, Fiori ME, Ferretti E, Gulino A, Bozzoni I & Caffarelli E 2007 The interplay between microRNAs and the neurotrophin receptor tropomyosin-related kinase C controls proliferation of human neuroblastoma cells. PNAS 104 7957-7962.
107. Lee YS & Dutta A 2007 The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes and Development 21 1025-1030.
108. Lee KH, Chen YL, Yeh SD, Hsiao M, Lin JT, Goan YG & Lu PJ 2009 MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation. Oncogene 28 3360-3370.
109. Letai AG 2008 Diagnosing and exploiting cancer's addiction to blocks in apoptosis. Nature Reviews. Cancer 8 121-132.
110. Li N, Fu H, Tie Y, Hu Z, Kong W, Wu Y & Zheng X 2009a miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. Cancer Letters 275 44-53.
111. Li T, Li D, Sha J, Sun P & Huang Y 2009b MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells. Biochemical and Biophysical Research Communications 383 280-285.
112. Lin SL, Chiang A, Chang D & Ying SY 2008 Loss of mir-146a function in hormone-refractory prostate cancer. RNA 14 417-424.
113. Linsley PS, Schelter J, Burchard J, Kibukawa M, Martin MM, Bartz SR, Johnson JM, Cummins JM, Raymond CK, Dai H et al. 2007 Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression. Molecular and Cellular Biology 27 2240-2252.
114. Löffler D, Brocke-Heidrich K, Pfeifer G, Stocsits C, Hackermüller J, Kretzschmar AK, Burger R, Gramatzki M, Blumert C, Bauer K et al. 2007 Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer. Blood 110 1330-1333.
115. Loureiro RM & D'Amore PA 2005 Transcriptional regulation of vascular endothelial growth factor in cancer. Cytokine and Growth Factor Reviews 16 77-89.
116. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA et al. 2005 MicroRNA expression profiles classify human cancers. Nature 435 834-838.
117. Lu Z, Liu M, Stribinskis V, Klinge CM, Ramos KS, Colburn NH & Li Y 2008 MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene 27 4373-4379.
118. Lujambio A & Esteller M 2007 CpG island hypermethylation of tumor suppressor microRNAs in human cancer. Cell Cycle 6 1455-1459.
119. Lujambio A, Calin GA, Villanueva A, Ropero S, Sánchez- Céspedes M, Blanco D, Montuenga LM, Rossi S, Nicoloso MS, Faller WJ et al. 2008 A microRNA DNA methylation signature for human cancer metastasis. PNAS 105 13556-13561.
120. Ma L, Teruya-Feldstein J & Weinberg RA 2007 Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449 682-688.
121. Marhaba R & Zoller M 2004 CD44 in cancer progression: adhesion, migration and growth regulation. Journal of Molecular Histology 35 211-231.
122. Marhaba R, Klingbeil P, Nuebel T, Nazarenko I, Buechler MW & Zoeller M 2008 CD44 and EpCAM: cancer-initiating cell markers. Current Molecular Medicine 8 784-804.
123. Mayr C, Hemann MT & Bartel DP 2007 Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 315 1576-1579.
124. Mees ST, Mardin WA, Wendel C, Baeumer N, Willscher E, Senninger N, Schleicher C, Colombo-Benkmann M & Haier J 2009a EP300 - a miRNA-regulated metastasis suppressor gene in ductal adenocarcinomas of the pancreas. International Journal of Cancer 126 114-124.
125. Mees ST, Mardin WA, Sielker S, Willscher E, Senninger N, Schleicher C, Colombo-Benkmann M & Haier J 2009b Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas. Annals of Surgical Oncology 16 2339-2350.
126. Meister G, Landthaler M, Dorsett Y & Tuschl T 2004 Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing. RNA 10 544-550.
127. Meng F, Henson R, Lang M, Wehbe H, Maheshwari S, Mendell JT, Jiang J, Schmittgen TD & Patel T 2006 Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 130 2113-2129.
128. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST & Patel T 2007 MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133 647-658.
129. Mertens-Talcott SU, Chintharlapalli S, Li X & Safe S 2007 The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer Research 67 11001-11011.
130. Michael MZ, O'Connor SM, van Holst Pellekaan NG, Young GP & James RJ 2003 Reduced accumulation of specific microRNAs in colorectal neoplasia. Molecular Cancer Research 1 882-891.
131. Migliore C, Petrelli A, Ghiso E, Corso S, Capparuccia L, Eramo A, Comoglio PM & Giordano S 2008 MicroRNAs impair MET-mediated invasive growth. Cancer Research 68 10128-10136.
132. Mitomo S, Maesawa C, Ogasawara S, Iwaya T, Shibazaki M, Yashima-Abo A, Kotani K, Oikawa H, Sakurai E, Izutsu N et al. 2008 Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines. Cancer Science 99 280-286.
133. Miura N, Sato R, Tsukamoto T, Shimizu M, Kabashima H, Takeda M, Takahashi S, Harada T, West JE, Drabkin H et al. 2009 A noncoding RNA gene on chromosome 10p15.3 may function upstream of hTERT. BMC Molecular Biology 10 5.
134. Moasser MM 2007 The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis. Oncogene 26 6469-6487.
135. Motoyama K, Inoue H, Nakamura Y, Uetake H, Sugihara K & Mori M 2008 Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family. Clinical Cancer Research 14 2334-2340.
136. Nam EJ, Yoon H, Kim SW, Kim H, Kim YT, Kim JH, Kim JW & Kim S 2008 MicroRNA expression profiles in serous ovarian carcinoma. Clinical Cancer Research 14 2690-2695.
137. Nicoloso MS, Spizzo R, Shimizu M, Rossi S & Calin GA 2009 MicroRNAs - the micro steering wheel of tumour metastases. Nature Reviews. Cancer 9 293-302.
138. Nikiforova MN, Tseng GC, Steward D, Diorio D & Nikiforov YE 2008 MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. Journal of Clinical Endocrinology and Metabolism 93 1600-1608.
139. Noonan EJ, Place RF, Pookot D, Basak S, Whitson JM, Hirata H, Giardina C & Dahiya R 2009 miR-449a targets HDAC-1 and induces growth arrest in prostate cancer. Oncogene 28 1714-1724.
140. O'Connell RM, Taganov KD, Boldin MP, Cheng G & Baltimore D 2007 MicroRNA-155 is induced during the macrophage inflammatory response. PNAS 104 1604-1609.
141. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV & Mendell JT 2005 c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435 839-843.
142. Ovcharenko D, Kelnar K, Johnson C, Leng N & Brown D 2007 Genome-scale microRNA and small interfering RNA screens identify small RNA modulators of TRAIL-induced apoptosis pathway. Cancer Research 67 10782-10788.
143. Ozen M, Creighton CJ, Ozdemir M & Ittmann M 2007 Widespread deregulation of microRNA expression in human prostate cancer. Oncogene 27 1788-1793.
144. Pallante P, Visone R, Ferracin M, Ferraro A, Berlingieri MT, Troncone G, Chiappetta G, Liu CG, Santoro M, Negrini M et al. 2006 MicroRNA deregulation in human thyroid papillary carcinomas. Endocrine-Related Cancer 13 497-508.
145. Park SM, Shell S, Radjabi AR, Schickel R, Feig C, Boyerinas B, Dinulescu DM, Lengyel E & Peter ME 2007 Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2. Cell Cycle 6 2585-2590.
146. Park SM, Gaur AB, Lengyel E & Peter ME 2008 The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes and Development 22 894-907.
147. Peinado H, Olmeda D & Cano A 2007 Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nature Reviews. Cancer 7 415-428.
148. Peter ME 2009 Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression. Cell Cycle 8 843-852.
149. Petrocca F, Visone R, Onelli MR, Shah MH, Nicoloso MS, de Martino I, Iliopoulos D, Pilozzi E, Liu CG, Negrini M et al. 2008 E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 13 272-286.
150. Pezzolesi MG, Platzer P, Waite KA & Eng C 2008 Differential expression of PTEN-targeting microRNAs miR-19a and miR-21 in Cowden syndrome. American Journal of Human Genetics 82 1141-1149.
151. Place RF, Li LC, Pookot D, Noonan EJ & Dahiya R 2008 MicroRNA-373 induces expression of genes with complementary promoter sequences. PNAS 105 1608-1613.
152. Ponta H, Sherman L & Herrlich PA 2003 CD44: from adhesion molecules to signalling regulators. Nature Reviews. Molecular Cell Biology 4 33-45.
153. Porkka KP, Pfeiffer MJ, Waltering KK, Vessella RL, Tammela TL & Visakorpi T 2007 MicroRNA expression profiling in prostate cancer. Cancer Research 67 6130-6135.
154. Qian ZR, Asa SL, Siomi H, Siomi MC, Yoshimoto K, Yamada S, Wang EL, Rahman MM, Inoue H, Itakura M et al. 2009 Overexpression of HMGA2 relates to reduction of the let-7 and its relationship to clinicopathological features in pituitary adenomas. Modern Pathology 22 431-441.
155. Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N, Bentwich Z & Oren M 2007 Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Molecular Cell 26 731-743.
156. Rigoutsos I 2009 New tricks for animal microRNAS: targeting of amino acid coding regions at conserved and nonconserved sites. Cancer Research 69 3245-3248.
157. Romero DG, Plonczynski MW, Carvajal CA, Gomez-Sanchez EP & Gomez-Sanchez CE 2008 Microribonucleic acid-21 increases aldosterone secretion
158. le Sage C, Nagel R, Egan DA, Schrier M, Mesman E, Mangiola A, Anile C, Maira G, Mercatelli N, Ciafrè SA et al. 2007 Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO Journal 26 3699-3708.
159. Sahai E 2007 Illuminating the metastatic process. Nature Reviews. Cancer 7 737-749.
160. Saito Y, Liang G, Egger G, Friedman JM, Chuang JC, Coetzee GA & Jones PA 2006 Specific activation of microRNA-127 with downregulation of the protooncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 9 435-443.
161. Salvi A, Sabelli C, Moncini S, Venturin M, Arici B, Riva P, Portolani N, Giulini SM, De Petro G & Barlati S 2009 MicroRNA-23b mediates urokinase and c-met down-modulation and a decreased migration of human hepatocellular carcinoma cells. FEBS Journal 276 2966-2982.
162. Sampson VB, Rong NH, Han J, Yang Q, Aris V, Soteropoulos P, Petrelli NJ, Dunn SP & Krueger LJ 2007 MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Research 67 9762-9770.
163. Schulte JH, Horn S, Otto T, Samans B, Heukamp LC, Eilers UC, Krause M, Astrahantseff K, Klein-Hitpass L, Buettner R et al. 2008 MYCN regulates oncogenic MicroRNAs in neuroblastoma. International Journal of Cancer 122 699-704.
164. Scott GK, Goga A, Bhaumik D, Berger CE, Sullivan CS & Benz CC 2007 Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b. Journal of Biological Chemistry 282 1479-1486.
165. Semenza GL 2000 HIF-1: using two hands to flip the angiogenic switch. Cancer Metastasis Reviews 19 59-65.
166. Semenza GL 2003 Angiogenesis in ischemic and neoplastic disorders. Annual Review of Medicine 54 17-28.
167. Sempere LF, Christensen M, Silahtaroglu A, Bak M, Heath CV, Schwartz G, Wells W, Kauppinen S & Cole CN 2007 Altered microRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Research 67 11612-11620.
168. Sengupta S, denBoon JA, Chen IH, Newton MA, Stanhope SA, Cheng YJ, Chen CJ, Hildesheim A, Sugden B& Ahlquist P 2008 MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. PNAS 105 5874-5878.
169. Seux M, Iovanna J, Dagorn JC & Dusetti NJ 2009 MicroRNAs in pancreatic ductal adenocarcinoma: new diagnostic and therapeutic clues. Pancreatology 9 66-72.
170. Shell S, Park SM, Radjabi AR, Schickel R, Kistner EO, Jewell DA, Feig C, Lengyel E & Peter ME 2007 Let-7 expression defines two differentiation stages of cancer. PNAS 104 11400-11405.
171. Sheu SY, Grabellus F, Schwertheim S, Handke S, Worm K & Schmid KW 2009 Lack of correlation between BRAF V600E mutational status and the expression profile of a distinct set of miRNAs in papillary thyroid carcinoma. Hormone and Metabolic Research 41 482-487.
172. Shi M & Guo N 2009 MicroRNA expression and its implications for the diagnosis and therapeutic strategies of breast cancer. Cancer Treatment Reviews 35 328-334.
173. Shi B, Sepp-Lorenzino L, Prisco M, Linsley P, deAngelis T & Baserga R 2007 MicroRNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells. Journal of Biological Chemistry 282 32582-32590.
174. Shimono Y, Zabala M, Cho RW, Lobo N, Dalerba P, Qian D, Diehn M, Liu H, Panula SP, Chiao E et al. 2009 Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 138 592-603.
175. Si ML, Zhu S, Wu H, Lu Z, Wu F & Mo YY 2007 miR-21-mediated tumor growth. Oncogene 26 2799-2803.
176. Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, Yu M, Vandenberg SR, Ginzinger DG, James CD, Costello JF et al. 2008 miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Medicine 6 14.
177. Spahn M, Kneitz S, Scholz CJ, Nico S, Rüdiger T, Ströbel P, Riedmiller H & Kneitz B 2009 Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence. International Journal of Cancer [in press].
178. Spizzo R, Nicoloso MS, Croce CM & Calin GA 2009 SnapShot: microRNAs in cancer. Cell 137 586-586e1.
179. Stewart SA & Weinberg RA 2000 Telomerase and human tumorigenesis. Seminars in Cancer Biology 10 399-406.
180. Su H, Yang JR, Xu T, Huang J, Xu L, Yuan Y & Zhuang SM 2009 MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Research 69 1135-1142.
181. Suárez Y, Fernández-Hernando C, Pober JS & Sessa WC 2007 Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells. Circulation Research 100 1164-1173.
182. Sun F, Fu H, Liu Q, Tie Y, Zhu J, Xing R, Sun Z & Zheng X 2008 Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest. FEBS Letters 582 1564-1568.
183. Sylvestre Y, De Guire V, Querido E, Mukhopadhyay UK, Bourdeau V, Major F, Ferbeyre G & Chartrand P 2007 An E2F/miR-20a autoregulatory feedback loop. Journal of Biological Chemistry 282 2135-2143.
184. Szafranska AE, Davison TS, John J, Cannon T, Sipos B, Maghnouj A, Labourier E & Hahn SA 2007 MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene 26 4442-4452.
185. Takagi T, Iio A, Nakagawa Y, Naoe T, Tanigawa N & Akao Y 2009 Decreased expression of microRNA-143 and -145 in human gastric cancers. Oncology 77 12-21.
186. Takakura S, Mitsutake N, Nakashima M, Namba H, Saenko VA, Rogounovitch TI, Nakazawa Y, Hayashi T, Ohtsuru A & Yamashita S 2008 Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells. Cancer Science 99 1147-1154.
187. Tanaka S, Sugimachi K, Yamashita Y, Shirabe K, Shimada M, Wands JR & Sugimachi K 2003 Angiogenic switch as a molecular target of malignant tumors. Journal of Gastroenterology 38 (Suppl 15) 93-97.
188. Tavazoie SF, Alarcón C, Oskarsson T, Padua D, Wang Q, Bos PD, Gerald WL & Massagué J 2008 Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451 147-152.
189. Tazawa H, Tsuchiya N, Izumiya M & Nakagama H 2007 Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. PNAS 104 15472-15477.
190. Tchernitsa OI, Sers C, Zuber J, Hinzmann B, Grips M, Schramme A, Lund P, Schwendel A, Rosenthal A & Schäfer R 2004 Transcriptional basis of KRAS oncogene-mediated cellular transformation in ovarian epithelial cells. Oncogene 23 4536-4555.
191. Thuault S, Tan EJ, Peinado H, Cano A, Heldin CH & Moustakas A 2008 HMGA2 and Smads co-regulate SNAIL1 expression during induction of epithelial-to-mesenchymal transition. Journal of Biological Chemistry 283 33437-33446.
192. Tili E, Michaille JJ, Gandhi V, Plunkett W, Sampath D & Calin GA 2007 miRNAs and their potential for use against cancer and other diseases. Future Oncology 3 521-537.
193. Tömböl Z, Szabó P, Molnár V, Wiener Z, Tölgyesi G, Horànyi J, Riesz P, Reismann P, Patócs A, Likó I et al. 2009 Integrative molecular-bioinformatics study of human adrenocortical tumors: microRNA, tissue specific target prediction and pathway analysis. Endocrine-Related Cancer 16 895-906.
194. Tsang J, Zhu J & van Oudenaarden A 2007 MicroRNA-mediated feedback and feedforward loops are recurrent network motifs in mammals. Molecular Cell 26 753-767.
195. Valastyan S, Reinhardt F, Benaich N, Calogrias D, Szász AM, Wang ZC, Brock JE, Richardson AL & Weinberg RA 2009Apleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 137 1032-1046.
196. Varambally S, Cao Q, Mani RS, Shankar S, Wang X, Ateeq B, Laxman B, Cao X, Jing X, Ramnarayanan K et al. 2008 Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science 322 1695-1699.
197. Visone R, Russo L, Pallante P, De Martino I, Ferraro A, Leone V, Borbone E, Petrocca F, Alder H, Croce CM et al. 2007a MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. Endocrine-Related Cancer 14 791-798.
198. Visone R, Pallante P, Vecchione A, Cirombella R, Ferracin M, Ferraro A, Volinia S, Coluzzi S, Leone V, Borbone E et al. 2007b Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene 26 7590-7595.
199. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M et al. 2006 A microRNA expression signature of human solid tumors defines cancer gene targets. PNAS 103 2257-2261.
200. Voorhoeve PM, le Sage C, Schrier M, Gillis AJ, Stoop H, Nagel R, Liu YP, van Duijse J, Drost J, Griekspoor A et al. 2006 A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 124 1169-1181.
201. Wang W, Mouneimne G, Sidani M, Wyckoff J, Chen X, Makris A, Goswami S, Bresnick AR & Condeelis JS 2006 The activity status of cofilin is directly related to invasion, intravasation, and metastasis of mammary tumors. Journal of Cell Biology 173 395-404.
202. Weber F, Teresi RE, Broelsch CE, Frilling A & Eng C 2006 A limited set of human microRNA is deregulated in follicular thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 91 3584-3591.
203. Webster RJ, Giles KM, Price KJ, Zhang PM, Mattick JS & Leedman PJ 2009 Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7. Journal of Biological Chemistry 284 5731-5741.
204. Wei JS, Song YK, Durinck S, Chen QR, Cheuk AT, Tsang P, Zhang Q, Thiele CJ, Slack A, Shohet J et al. 2008 The MYCN oncogene is a direct target of miR-34a. Oncogene 27 5204-5213.
205. Welch C, Chen Y & Stallings RL 2007 MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 26 5017-5022.
206. Wolf K, Mazo I, Leung H, Engelke K, von Andrian UH, Deryugina EI, Strongin AY, Bröcker EB & Friedl P 2003 Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. Journal of Cell Biology 160 267-277.
207. Wong CW, Lee A, Shientag L, Yu J, Dong Y, Kao G, Al-Mehdi AB, Bernhard EJ & Muschel RJ 2001 Apoptosis: an early event in metastatic inefficiency. Cancer Research 61 333-338.
208. Woods K, Thomson JM & Hammond SM 2007 Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors. Journal of Biological Chemistry 282 2130-2134.
209. Wu MY & Hill CS 2009 Tgf-beta superfamily signaling in embryonic development and homeostasis. Developmental Cell 16 329-343.
210. Würdinger T, Tannous BA, Saydam O, Skog J, Grau S, Soutschek J, Weissleder R, Breakefield XO & Krichevsky AM 2008 miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. Cancer Cell 14 382-393.
211. Yamamichi N, Shimomura R, Inada K, Sakurai K, Haraguchi T, Ozaki Y, Fujita S, Mizutani T, Furukawa C, Fujishiro M et al. 2009 Locked nucleic acid in situ hybridization analysis of miR-21 expression during colorectal cancer development. Clinical Cancer Research 15 4009-4016.
212. Yang WJ, Yang DD, Na S, Sandusky GE, Zhang Q & Zhao G 2005 Dicer is required for embryonic angiogenesis during mouse development. Journal of Biological Chemistry 280 9330-9335.
213. Yang H, Kong W, He L, Zhao JJ, O'Donnell JD, Wang J, Wenham RM, Coppola D, Kruk PA, Nicosia SV et al. 2008 MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Research 68 425-433.
214. Zhang L, Huang J, Yang N, Greshock J, Megraw MS, Giannakakis A, Liang S, Naylor TL, Barchetti A, Ward MR et al. 2006 microRNAs exhibit high frequency genomic alterations in human cancer. PNAS 103 9136-9141.
215. Zhang L, Volinia S, Bonome T, Calin GA, Greshock J, Yang N, Liu CG, Giannakakis A, Alexiou P, Hasegawa K et al. 2008 Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. PNAS 105 7004-7009.
216. Zhang Y, Guo J, Li D, Xiao B, Miao Y, Jiang Z & Zhuo H 2009 Down-regulation of miR-31 expression in gastric cancer tissues and its clinical significance. Medical Oncology [in press].
217. Zhao L, Samuels T, Winckler S, Korgaonkar C, Tompkins V, Horne MC & Quelle DE 2003 Cyclin G1 has growth inhibitory activity linked to the ARF-Mdm2-p53 and pRb tumor suppressor pathways. Molecular Cancer Research 1 195-206.
218. Zhu S, Wu H, Wu F, Nie D, Sheng S & Mo YY 2008 MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Research 18 350-359.